SYNVISC HYLAN G-F 20, 3x2ml 8mg/ml

SYNVISC® (Hylan G-F 20) is an FDA-approved medical device designed to alleviate knee pain associated with osteoarthritis (OA), particularly in patients who have not responded adequately to conservative non-pharmacologic therapies and simple analgesics like acetaminophen.

Key Benefits
Effective Pain Relief: Clinical studies have demonstrated that SYNVISC can provide significant knee pain relief, with some patients experiencing improvement as early as one week after the initial injection.

Long-Lasting Results: A single treatment cycle of SYNVISC has been shown to offer pain relief for up to six months, reducing the need for frequent interventions.

Enhanced Joint Function: By supplementing the synovial fluid in the knee, SYNVISC helps restore the joint’s natural lubrication and cushioning, leading to improved mobility and function.

Alternative to Oral Pain Medications: For patients seeking to minimize the use of systemic pain relievers, SYNVISC offers a localized treatment option that can reduce dependence on oral analgesics.

Well-Tolerated Treatment: SYNVISC has a favorable safety profile, with side effects generally being mild and transient.